|
||
© The Rockefeller University Press,
0021-9525/1999//1049 $5.00
The Journal of Cell Biology, Volume 147, Number 5,
, 1999 1049-1062
Original Article |
Programmed Cell Death of Embryonic Motoneurons Triggered through the FAS Death Receptor
chris{at}ibdm.univ-mrs.fr
About 50% of spinal motoneurons undergo programmed cell death (PCD) after target contact, but little is known about how this process is initiated. Embryonic motoneurons coexpress the death receptor Fas and its ligand FasL at the stage at which PCD is about to begin. In the absence of trophic factors, many motoneurons die in culture within 2 d. Most (75%) of these were saved by Fas-Fc receptor body, which blocks interactions between Fas and FasL, or by the caspase-8 inhibitor tetrapeptide IETD. Therefore, activation of Fas by endogenous FasL underlies cell death induced by trophic deprivation. In the presence of neurotrophic factors, exogenous Fas activators such as soluble FasL or anti-Fas antibodies triggered PCD of 40–50% of purified motoneurons over the following 3–5 d; this treatment led to activation of caspase-3, and was blocked by IETD. Sensitivity to Fas activation is regulated: motoneurons cultured for 3 d with neurotrophic factors became completely resistant. Levels of Fas expressed by motoneurons varied little, but FasL was upregulated in the absence of neurotrophic factors. Motoneurons resistant to Fas activation expressed high levels of FLICE-inhibitory protein (FLIP), an endogenous inhibitor of caspase-8 activation. Our results suggest that Fas can act as a driving force for motoneuron PCD, and raise the possibility that active triggering of PCD may contribute to motoneuron loss during normal development and/or in pathological situations.
Key Words: motoneuron Fas ligand APO-1/CD95 neuron killing caspases
© 1999 The Rockefeller University Press
Abbreviations used in this paper: BDNF, brain-derived neurotrophic factor; CNTF, ciliary neurotrophic factor; CT-1, cardiotrophin-1; DAPI, 4',6-diamidino-2-phenylindole dihydrochloride; DIV, day(s) in vitro; FADD, Fas-associated death domain; Fas-Fc, recombinant human APO-1/Fas–Fc IgG; GDNF, glial cell line–derived neurotrophic factor; L, ligand; NTF, neurotrophic factors; PCD, programmed cell death; RT, reverse transcription; s, soluble.
|
|